凯时与晴尔治疗糖尿病周围神经病变疗效比较  

Effect comparison between Lipo PGE_1 and Azagrel in treatment of diabetic peripheral neuropathy

作　　者：于为东[1] 

机构地区：[1]吉林省第二荣复军人医院,吉林梨树136500

出　　处：《中国医药导报》2010年第33期40-41,共2页China Medical Herald

摘　　要：目的:观察并比较凯时、晴尔对糖尿病周围神经病变的治疗作用。方法:回顾性分析2006年5月～2009年7月我院确诊的2型糖尿病合并周围神经病变患者80例,随机分为凯时治疗组44例,晴尔治疗组36例。观察两组治疗前后症状改善情况,并用肌电图测量神经传导速度。结果:两组用药后自觉症状及神经传导速度均有所改善,凯时组明显优于晴尔组(P<0.05)。结论:凯时与晴尔治疗糖尿病周围神经病变均有效,且凯时的治疗效果优于晴尔,可作为治疗糖尿病周围神经病变的理想的药物。Objective：To compare the clinical effect of Lipo pGE1 and Azagrel in treatment of diabetic peripheral neu-ropathy（DPN）.Methods：80 patients with DPN were divided into Lipo pGE1 group（n=44） and Azagrel group（n=36）,they were given Lipo PGE1 or Azagrel for 2 weeks,and the curative effects were compared.Results：The improvement of DPN symptoms and signs or nerve conduction speeds in Lipo PGE1 group were obviously better than those Azagrel group（P0.05）.Conclusion：Lipo PGE1 and Azagrel are effective treatment methods of DPN,and Lipo PGE1 is better than Azagrel,and can be used as ideal drug in treatment of DPN.

关 键 词：凯时 晴尔 糖尿病 周围神经病变 

分 类 号：R969.4[医药卫生—药理学]